The real-life findings showed that treatment with brodalumab improved health-related quality of life (HRQOL) for patients but itching prevented complete improvement. Despite achieving clear or almost ...

In both trials, envudeucitinib showed greater skin clearance than placebo on both co-primary endpoints at week 16.

Learn what collagen is, why it may or may not have benefits for psoriasis, according to experts, and what the research has found so far.

Please provide your email address to receive an email when new articles are posted on . BOSTON — Improvement in plaque psoriasis itch and severity, including in intertriginous areas, was significant ...

A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion containing nucleic acids that transiently disrupt inflammatory gene activity. This ionic ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

Please provide your email address to receive an email when new articles are posted on . Patient reported data from two phase 3 trials found roflumilast cream 0.3% significantly reduced itch severity ...

DENVER — The topical TrkA kinase inhibitor CT327 reduces chronic itch in patients with psoriasis, according to results from a new study. "This is an unmet need," said Gil Yosipovitch, MD, professor of ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...